Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 1697 of 1714:
1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707
Gene Compound Assay Inh Ic50 Ki View
bradykinin receptor, beta 2 OXICONAZOLE Bradykinin B2 -16% NoneNone NoneNone View
bradykinin receptor B2 OXICONAZOLE Bradykinin B2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel associated protein 1 SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel associated protein 2 SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B MYCOPHENOLIC ACID Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
adenosine A2a receptor FLEROXACIN Adenosine A2A -16% NoneNone NoneNone View
mitogen activated protein kinase 1 HYDRALAZINE Protein Serine/Threonine Kinase, ERK2 -16% NoneNone NoneNone View
mitogen-activated protein kinase 1 HYDRALAZINE Protein Serine/Threonine Kinase, ERK2 -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 FLEROXACIN GABAA, Agonist Site -16% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) S(-)-CARBIDOPA Imidazoline I2, Central -16% NoneNone NoneNone View
interleukin 1 receptor, type I S(-)-CARBIDOPA Interleukin IL-1 alpha -16% NoneNone NoneNone View
interleukin 8 receptor, alpha TRANILAST Chemokine CXCR1(IL-8A) -16% NoneNone NoneNone View
chemokine (C-C motif) receptor 4 CARBACHOL Chemokine CCR4 -16% NoneNone NoneNone View
dopamine receptor D4 TOLNAFTATE Dopamine D4.2 -16% NoneNone NoneNone View
platelet derived growth factor receptor, alpha polypeptide FLURBIPROFEN Platelet-Derived Growth Factor (PDGF) -16% NoneNone NoneNone View
platelet-derived growth factor receptor, alpha polypeptide FLURBIPROFEN Platelet-Derived Growth Factor (PDGF) -16% NoneNone NoneNone View
platelet derived growth factor receptor, beta polypeptide FLURBIPROFEN Platelet-Derived Growth Factor (PDGF) -16% NoneNone NoneNone View
platelet-derived growth factor receptor, beta polypeptide FLURBIPROFEN Platelet-Derived Growth Factor (PDGF) -16% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B TOLMETIN Serotonin 5-HT2B -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 1 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, pi MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
AT hook, DNA binding motif, containing 1 (DBSS) MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, theta MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 2 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 2 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 1 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, delta MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 MECLOFENAMIC ACID GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
glycine receptor, alpha 3 MELOXICAM Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, alpha 1 subunit MELOXICAM Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, beta subunit MELOXICAM Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, alpha 2 subunit MELOXICAM Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
insulin receptor QUINOLONE, CHEMI-LINZ / CYANAMID Insulin -16% NoneNone NoneNone View
insulin receptor QUINOLONE, CHEMI-LINZ / CYANAMID Insulin -16% NoneNone NoneNone View
histamine receptor H 2 SULINDAC SULFIDE Histamine H2 -16% NoneNone NoneNone View
dopamine receptor D4 TRANEXAMIC ACID Dopamine D4.2 -16% NoneNone NoneNone View
progesterone receptor 4-METHYLPYRAZOLE Progesterone -16% NoneNone NoneNone View
progesterone receptor 4-METHYLPYRAZOLE Progesterone -16% NoneNone NoneNone View
aldo-keto reductase family 1, member B4 (aldose reductase) ARTEMISININ Aldose Reductase -16% NoneNone NoneNone View
aldo-keto reductase family 1, member B1 (aldose reductase) ARTEMISININ Aldose Reductase -16% NoneNone NoneNone View
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) ARTEMISININ Aldose Reductase -16% NoneNone NoneNone View
aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) ARTEMISININ Aldose Reductase -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D LANSOPRAZOLE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C LANSOPRAZOLE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B LANSOPRAZOLE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A LANSOPRAZOLE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) LANSOPRAZOLE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B LANSOPRAZOLE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 LANSOPRAZOLE Serotonin Transporter -16% NoneNone NoneNone View
adrenergic receptor, alpha 2b FELBINAC Adrenergic alpha2B -16% NoneNone NoneNone View
cannabinoid receptor 1 (brain) LABETALOL Cannabinoid CB1 -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D MONOBENZONE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C MONOBENZONE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B MONOBENZONE Glutamate, NMDA, Agonism -16% NoneNone NoneNone View
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) AMIKACIN Vascular Endothelinal Growth Factor (VEGF) -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 9 CHLORTHALIDONE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 10 CHLORTHALIDONE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, epsilon polypeptide CHLORTHALIDONE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 4 CHLORTHALIDONE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 5 CHLORTHALIDONE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) CHLORTHALIDONE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 AMRINONE Cyclooxygenase COX-1 -16% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) AMRINONE Cyclooxygenase COX-1 -16% NoneNone NoneNone View
chemokine (C-C motif) receptor 5 CLARITHROMYCIN Chemokine CCR5 -16% NoneNone NoneNone View
tachykinin receptor 1 CLARITHROMYCIN Tachykinin NK1 -16% NoneNone NoneNone View
melanocortin 5 receptor ANISINDIONE Melanocortin MC5 -16% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase ANASTROZOLE HMG-CoA Reductase -16% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase ANASTROZOLE HMG-CoA Reductase -16% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 ETHACRYNIC ACID Adrenergic, Norepinephrine Transporter -16% NoneNone NoneNone View
chemokine (C-C motif) receptor 4 EDARAVONE Chemokine CCR4 -16% NoneNone NoneNone View
histamine receptor H 2 COLISTIN Histamine H2 -16% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 RO 20-1724 Serotonin Transporter -16% NoneNone NoneNone View
phosphodiesterase 3B CIMETIDINE Phosphodiesterase PDE3 -16% NoneNone NoneNone View
phosphodiesterase 3A CIMETIDINE Phosphodiesterase PDE3 -16% NoneNone NoneNone View
platelet derived growth factor receptor, alpha polypeptide TRIMETHADIONE Platelet-Derived Growth Factor (PDGF) -16% NoneNone NoneNone View
platelet-derived growth factor receptor, alpha polypeptide TRIMETHADIONE Platelet-Derived Growth Factor (PDGF) -16% NoneNone NoneNone View
platelet derived growth factor receptor, beta polypeptide TRIMETHADIONE Platelet-Derived Growth Factor (PDGF) -16% NoneNone NoneNone View
platelet-derived growth factor receptor, beta polypeptide TRIMETHADIONE Platelet-Derived Growth Factor (PDGF) -16% NoneNone NoneNone View
arginine vasopressin receptor 1A (R)-BICALUTAMIDE Vasopressin V1A -16% NoneNone NoneNone View
adrenergic receptor, alpha 1d (Non-specific probe) CINNAMALDEHYDE Adrenergic alpha1D -16% NoneNone NoneNone View
glycine receptor, alpha 3 CINNAMALDEHYDE Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, alpha 1 subunit CINNAMALDEHYDE Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, beta subunit CINNAMALDEHYDE Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, alpha 2 subunit CINNAMALDEHYDE Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 9 CINNAMALDEHYDE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 10 CINNAMALDEHYDE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, epsilon polypeptide CINNAMALDEHYDE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 4 CINNAMALDEHYDE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 5 CINNAMALDEHYDE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) CINNAMALDEHYDE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
DNA encoding receptor of vasoactive intestinal polypeptide BETAHISTINE Vasoactive Intestinal Peptide VIP1 -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 5 METHIMAZOLE Glutamate, Kainate -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 4 METHIMAZOLE Glutamate, Kainate -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 3 METHIMAZOLE Glutamate, Kainate -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 2 METHIMAZOLE Glutamate, Kainate -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 1 METHIMAZOLE Glutamate, Kainate -16% NoneNone NoneNone View
neuropeptide Y receptor Y2 BENZYL ALCOHOL Neuropeptide Y2 -16% NoneNone NoneNone View
neuropeptide Y receptor Y2 BENZYL ALCOHOL Neuropeptide Y2 -16% NoneNone NoneNone View
mitogen activated protein kinase 3 (RS)-AMPA Protein Serine/Threonine Kinase, ERK1 -16% NoneNone NoneNone View
mitogen-activated protein kinase 3 (RS)-AMPA Protein Serine/Threonine Kinase, ERK1 -16% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) TEMAFLOXACIN CYP450-2C9 Inhibition -16% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 TEMAFLOXACIN CYP450-2C9 Inhibition -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 5 (DBSS) (RS)-AMPA Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 1b (RS)-AMPA Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 1a (RS)-AMPA Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 4 (RS)-AMPA Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) (RS)-AMPA Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 8 (RS)-AMPA Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CHOLECALCIFEROL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 CHOLECALCIFEROL Cyclooxygenase COX-1 -16% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) CHOLECALCIFEROL Cyclooxygenase COX-1 -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 1 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, pi HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
AT hook, DNA binding motif, containing 1 (DBSS) HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, theta HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 2 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 2 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 1 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, delta HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 HALOPROGIN GABAA, Benzodiazepine, Central -16% NoneNone NoneNone View
dopamine receptor D1A 3-AMINOBENZAMIDE Dopamine D1 -16% NoneNone NoneNone View
dopamine receptor D4 AMINOPTERIN Dopamine D4.2 -16% NoneNone NoneNone View
adrenergic receptor, beta 3 SODIUM NITROPRUSSIDE Adrenergic beta3 -16% NoneNone NoneNone View
adrenergic receptor, beta 1 SODIUM NITROPRUSSIDE Adrenergic beta1 -16% NoneNone NoneNone View
adrenergic, beta-1-, receptor SODIUM NITROPRUSSIDE Adrenergic beta1 -16% NoneNone NoneNone View
leukotriene C4 synthase DIPHENHYDRAMINE Leukotriene C4 Synthetase -16% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) PENICILLIC ACID Protein Tyrosine Kinase, HER2 Receptor -16% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 PENICILLIC ACID Dopamine Transporter -16% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 PHENTOLAMINE Potassium Channel [KATP] -16% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 PHENTOLAMINE Potassium Channel [KATP] -16% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 PHENTOLAMINE Potassium Channel [KATP] -16% NoneNone NoneNone View
androgen receptor PHENTOLAMINE Testosterone -16% NoneNone NoneNone View
cannabinoid receptor 1 (brain) SOTALOL Cannabinoid CB1 -16% NoneNone NoneNone View
thromboxane A synthase 1 VALDECOXIB Thromboxane Synthetase -16% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) VALDECOXIB Thromboxane Synthetase -16% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase DAPIPRAZOLE CYP450-1A2 Inhibition -16% NoneNone NoneNone View
phosphodiesterase 4A, cAMP specific PROGLUMIDE Phosphodiesterase PDE4 -16% NoneNone NoneNone View
phosphodiesterase 4C, cAMP-specific PROGLUMIDE Phosphodiesterase PDE4 -16% NoneNone NoneNone View
phosphodiesterase 4D PROGLUMIDE Phosphodiesterase PDE4 -16% NoneNone NoneNone View
phosphodiesterase 4B, cAMP specific PROGLUMIDE Phosphodiesterase PDE4 -16% NoneNone NoneNone View
epidermal growth factor receptor SALSALATE Protein Tyrosine Kinase, EGF Receptor -16% NoneNone NoneNone View
monoamine oxidase A SALSALATE Monoamine Oxidase MAOA -16% NoneNone NoneNone View
monoamine oxidase A SALSALATE Monoamine Oxidase MAOA -16% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 8 PENICILLIN G Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) SODIUM ORTHOVANADATE Sodium Channel, Site 2 -16% NoneNone NoneNone View